Protagonist Therapeutics Inc (PTGX)
Quick ratio
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 172,568 | 186,727 | 230,527 | 235,382 | 127,686 | 125,744 | 152,816 | 120,237 | 98,477 | 123,665 | 120,542 | 192,412 | 83,000 | 117,358 | 83,625 | 146,242 | 60,215 | 33,006 | 50,195 | 71,143 |
| Short-term investments | US$ in thousands | 150,067 | 154,890 | 90,224 | 78,019 | 103,073 | 111,611 | 114,621 | 171,653 | 206,800 | 203,235 | 193,759 | 161,868 | 190,500 | 188,500 | 110,349 | 62,423 | 57,298 | 100,011 | 87,497 | 54,958 |
| Receivables | US$ in thousands | — | — | — | 50 | 51 | 3,852 | 620 | 3,363 | 28,504 | 5,333 | 4,509 | 9,855 | 5,819 | 3,821 | 3,324 | 3,273 | 3,747 | 7,499 | 2,118 | 6,310 |
| Total current liabilities | US$ in thousands | 39,910 | 21,274 | 27,867 | 26,398 | 23,229 | 31,179 | 36,754 | 40,088 | 43,456 | 44,016 | 39,156 | 42,973 | 34,515 | 40,241 | 38,563 | 35,360 | 36,372 | 35,406 | 30,776 | 33,323 |
| Quick ratio | 8.08 | 16.06 | 11.51 | 11.87 | 9.94 | 7.74 | 7.29 | 7.37 | 7.68 | 7.55 | 8.14 | 8.47 | 8.09 | 7.70 | 5.12 | 5.99 | 3.33 | 3.97 | 4.54 | 3.97 |
March 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($172,568K
+ $150,067K
+ $—K)
÷ $39,910K
= 8.08
The quick ratio of Protagonist Therapeutics Inc has shown fluctuations over the periods analyzed. The quick ratio indicates the company's ability to meet its short-term obligations with its most liquid assets.
From Dec 31, 2019, to Mar 31, 2024, the quick ratio ranged from a low of 3.33 to a high of 16.06. The quick ratio generally remained above the ideal value of 1, indicating that Protagonist Therapeutics Inc has a strong ability to cover its short-term liabilities with its current liquid assets.
The quick ratio experienced a significant increase from Sep 30, 2020, to Dec 31, 2023, indicating strengthening liquidity position during this period. However, there were fluctuations in the quick ratio over other periods, suggesting variations in the company's ability to quickly cover its short-term obligations.
Overall, the trend of the quick ratio for Protagonist Therapeutics Inc reflects a generally healthy liquidity position, with some fluctuations indicating changing levels of short-term financial strength during the periods analyzed.
Peer comparison
Mar 31, 2024